GlassScriptPhysician profile
Wendy Martinez
NPI 1265504666
$5,733.06
in general payments reported to CMS, 2019-2025
42 companies · $664 in 2025
The $664 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $294 · 2021: $971 · 2022: $905 · 2023: $1,437 · 2024: $764 · 2025: $664.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,672 · Education: $193.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,671.70 |
| Education | $193.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $621.14 | 2019-2025 | |
| Astellas Pharma US INC | $557.83 | 2019-2025 | Veozah |
| Mayne Pharma Commercial LLC | $464.92 | 2022-2025 | |
| Amgen INC. | $425.64 | 2019-2024 | Prolia, Evenity |
| Pfizer INC. | $411.19 | 2019-2024 | |
| Exeltis, USA INC. | $347.64 | 2020-2025 | Slynd |
| Therapeuticsmd, INC. | $312.25 | 2019-2022 | |
| Evofem Biosciences, INC. | $252.83 | 2021-2024 | Phexxi |
| Avion Pharmaceuticals | $223.82 | 2019-2022 | |
| Exact Sciences Corporation | $198.47 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $177.52 | 2019-2025 | |
| Shield Therapeutics INC | $171.88 | 2023-2025 | Accrufer |
| Novo Nordisk INC | $156.43 | 2020-2023 | Wegovy |
| Sumitomo Pharma America, INC. | $137.54 | 2023-2025 | Myfembree |
| Mylan Pharmaceuticals INC. | $133.92 | 2020-2022 |
Show all 42 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $130.80 | 2019-2024 | Gardasil 9, Gardasil |
| Myovant Sciences INC. | $108.27 | 2021-2022 | |
| Agile Therapeutics, INC. | $102.52 | 2021-2022 | |
| Hologic Sales and Service, LLC | $101.69 | 2019-2025 | Aptima, Myosure Tissue Removal Device |
| Daiichi Sankyo INC. | $96.26 | 2020-2022 | |
| Millicent US INC | $82.45 | 2019-2025 | Intrarosa, Femring, Femlyv |
| Coopersurgical, INC. | $55.48 | 2023-2024 | Paragard T 380a, Endosee |
| Organon LLC | $47.27 | 2021-2025 | Nexplanon |
| Cumberland Pharmaceuticals, INC. | $43.37 | 2019-2024 | Kristalose |
| Amag Pharmaceuticals, INC. | $41.86 | 2019 | |
| Radius Health, INC. | $40.18 | 2019-2023 | |
| Lilly USA, LLC | $34.47 | 2025 | Zepbound, Mounjaro |
| Sage Therapeutics, LLC | $32.56 | 2024-2025 | Zurzuvae |
| Astellas Pharma Global Development | $23.04 | 2023 | Veozah |
| Tempus Ai, INC | $22.34 | 2025 | Xt Cdx |
| Abiomed | $22.04 | 2025 | |
| Axonics, INC. | $19.72 | 2022 | |
| Vivus LLC | $17.27 | 2024 | Pancreaze |
| Lupin INC. | $15.08 | 2019 | |
| Scynexis, INC. | $14.81 | 2022 | |
| Mission Pharmacal Company | $13.91 | 2019 | |
| Ascend Therapeutics US, LLC | $13.85 | 2021 | |
| Allergan, INC. | $13.37 | 2019 | |
| Duchesnay USA Incorporated | $12.40 | 2019 | |
| Endo Pharmaceuticals INC. | $12.22 | 2019 | |
| Aspira Women'S Health INC | $11.61 | 2023 | Ova1 |
| Ferring Pharmaceuticals INC. | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Martinez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.